JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Intellia Therapeutics
NTLA
$1.79B
| $6.52M | ﹤0.01% |
310,281
+86,659
| +39% | +$1.47M |
2017 Q4
10 quarters
|
|
2152
Groupon
GRPN
$802M
| $6.51M | ﹤0.01% |
359,393
+62,524
| +21% | +$1.39M |
2013 Q2
28 quarters
|
|
|
RETA
2153
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.51M | ﹤0.01% |
41,735
-413
| -1% | -$62.8K |
2016 Q2
16 quarters
|
|
2154
Nokia
NOK
$57.1B
| $6.51M | ﹤0.01% |
1,479,795
-2,467,700
| -63% | -$9.32M |
2013 Q2
28 quarters
|
|
2155
TriNet
TNET
$2.93B
| $6.5M | ﹤0.01% |
106,696
-11,289
| -10% | -$564K |
2014 Q2
24 quarters
|
|
2156
CALL
NIO
NIO
$8.57B
| $6.5M | ﹤0.01% |
841,500
-100,000
| -11% | -$440K |
2019 Q1
5 quarters
|
|
|
LVGO
2157
CALL
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $6.5M | ﹤0.01% |
+86,400
| New | +$4.52M |
2020 Q2
0 quarters
|
|
2158
CALL
Lam Research
LRCX
$433B
| $6.47M | ﹤0.01% |
200,000
| – | – |
2019 Q1
5 quarters
|
|
2159
Green Plains
GPRE
$1.06B
| $6.47M | ﹤0.01% |
633,058
-127,363
| -17% | -$938K |
2013 Q2
28 quarters
|
|
2160
Ares Management
ARES
$26.6B
| $6.46M | ﹤0.01% |
162,585
-382,789
| -70% | -$13.5M |
2016 Q4
14 quarters
|
|
2161
Apple Hospitality REIT
APLE
$3.87B
| $6.45M | ﹤0.01% |
667,444
+124,020
| +23% | +$1.18M |
2015 Q4
18 quarters
|
|
|
PFC
2162
DELISTED
Premier Financial Corp. Common Stock
PFC
| $6.44M | ﹤0.01% |
364,673
-10,307
| -3% | -$167K |
2013 Q2
28 quarters
|
|
|
PVG
2163
DELISTED
PRETIUM RESOURCES INC.
PVG
| $6.43M | ﹤0.01% |
+765,094
| New | +$6.24M |
2020 Q2
0 quarters
|
|
2164
Kemper
KMPR
$1.52B
| $6.42M | ﹤0.01% |
88,519
+5,541
| +7% | +$371K |
2015 Q1
21 quarters
|
|
|
AVTA
2165
DELISTED
Avantax, Inc. Common Stock
AVTA
| $6.4M | ﹤0.01% |
560,607
+204,776
| +58% | +$2.57M |
2013 Q2
28 quarters
|
|
2166
Independent Bank Corp
IBCP
$797M
| $6.4M | ﹤0.01% |
430,723
+7,613
| +2% | +$105K |
2015 Q3
19 quarters
|
|
|
DFPHU
2167
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
| $6.39M | ﹤0.01% |
600,000
+41,150
| +7% | +$415K |
2020 Q1
1 quarter
|
|
|
CBPO
2168
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $6.37M | ﹤0.01% |
62,383
+44,336
| +246% | +$4.74M |
2017 Q3
11 quarters
|
|
2169
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
| $6.36M | ﹤0.01% |
121,842
+22,793
| +23% | +$1.14M |
2017 Q2
12 quarters
|
|
2170
PUT
Alphabet (Google) Class C
GOOG
$4.21T
| $6.36M | ﹤0.01% |
90,000
-482,000
| -84% | -$32.5M |
2016 Q2
16 quarters
|
|
2171
The Bancorp
TBBK
$1.97B
| $6.36M | ﹤0.01% |
649,075
+6,143
| +1% | +$46.3K |
2017 Q3
11 quarters
|
|
|
BRY
2172
DELISTED
Berry Corp
BRY
| $6.35M | ﹤0.01% |
1,314,097
+520,380
| +66% | +$2.01M |
2018 Q3
7 quarters
|
|
2173
Wyndham Hotels & Resorts
WH
$5.29B
| $6.34M | ﹤0.01% |
148,739
-2,312,461
| -94% | -$94.3M |
2018 Q2
8 quarters
|
|
2174
CALL
Expedia Group
EXPE
$31.2B
| $6.33M | ﹤0.01% |
77,000
+47,000
| +157% | +$3.42M |
2017 Q4
10 quarters
|
|
2175
Cavco Industries
CVCO
$4.43B
| $6.33M | ﹤0.01% |
32,809
+26,402
| +412% | +$4.33M |
2015 Q4
18 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.